Pennant Group Inc（PNTG）財務資料PNTGPennant Group Inc

The Pennant Group, Inc. (PNTG) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medicare, accounting for 50.9% of total sales, equivalent to $151.65M. Other significant revenue streams include Private and other and Medicaid. Understanding this composition is critical for investors evaluating how PNTG navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, The Pennant Group, Inc. maintains a gross margin of 12.91%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.22%, while the net margin is 3.66%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively PNTG converts its operational activities into shareholder value.

In the context of the broader market, PNTG competes directly with industry leaders such as AZTA and AGL. With a market capitalization of $1.40B, it holds a significant position in the sector. When comparing efficiency, PNTG's gross margin of 12.91% stands against AZTA's 44.89% and AGL's 12.82%. Such benchmarking helps identify whether The Pennant Group, Inc. is trading at a premium or discount relative to its financial performance.

Pennant Group has shown consistent revenue growth, with total revenue increasing from $188.89 million in Q4 2024 to $297.98 million in Q2 2026. The net income has also improved, reaching $9.08 million in Q2 2026, reflecting strong operational performance.